The more things change the more they remain the same or, what you gain in the swing you lose on the roundabout. Despite the vaccine, Europe is back where it started, becoming the focal point of the Covid-19 pandemic...

The pharmaceutical companies Biogen and Eisai last week announced that a monoclonal antibody treatment reduced cognitive decline by 27% in people with early stage Alzheimer’s compared with those on a placebo after 18 months. www.science.org/content/article/news-glance-ai-regulation-renewable-energy-and-alzheimer-s-therapy? Lecanemab belongs to a class...